Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Azacitidine Before Stem-Cell Transplant for MDS Improves Survival

NEW YORK (Reuters Health) – Patients with myelodysplastic syndrome (MDS) who are treated with azacitidine before allogeneic stem-cell transplantation fare as well as patients receiving standard pre-transplant induction chemotherapy, according to a...

Reuters Health • The Doctor's Channel Daily Newscast

Best Antithymocyte Globulin Dose Defined Before Transplant for Hematologic Disease

NEW YORK (Reuters Health) – Reduced-intensity conditioning that includes two daily 2.5-mg/kg doses of antithymocyte globulin before allogeneic stem-cell transplantation for hematologic malignancy significantly reduces graft-versus-host disease (GvHD)...

Reuters Health • The Doctor's Channel Daily Newscast

Azacitidine Before Stem-Cell Transplant for MDS Improves Survival

NEW YORK (Reuters Health) – Patients with myelodysplastic syndrome (MDS) who are treated with azacitidine before allogeneic stem-cell transplantation fare as well as patients receiving standard pre-transplant induction chemotherapy, according to a...